318 related articles for article (PubMed ID: 28335839)
21. Target organ damage in African American hypertension: role of APOL1.
Freedman BI; Murea M
Curr Hypertens Rep; 2012 Feb; 14(1):21-8. PubMed ID: 22068337
[TBL] [Abstract][Full Text] [Related]
22. APOL1 G1 genotype modifies the association between HDLC and kidney function in African Americans.
Bentley AR; Divers J; Shriner D; Doumatey AP; Gutiérrez OM; Adeyemo AA; Freedman BI; Rotimi CN
BMC Genomics; 2015 May; 16(1):421. PubMed ID: 26025194
[TBL] [Abstract][Full Text] [Related]
23. Increased burden of cardiovascular disease in carriers of APOL1 genetic variants.
Ito K; Bick AG; Flannick J; Friedman DJ; Genovese G; Parfenov MG; Depalma SR; Gupta N; Gabriel SB; Taylor HA; Fox ER; Newton-Cheh C; Kathiresan S; Hirschhorn JN; Altshuler DM; Pollak MR; Wilson JG; Seidman JG; Seidman C
Circ Res; 2014 Feb; 114(5):845-50. PubMed ID: 24379297
[TBL] [Abstract][Full Text] [Related]
24. APOL1 risk variants, race, and progression of chronic kidney disease.
Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
[TBL] [Abstract][Full Text] [Related]
25. Gene-gene interactions in APOL1-associated nephropathy.
Divers J; Palmer ND; Lu L; Langefeld CD; Rocco MV; Hicks PJ; Murea M; Ma L; Bowden DW; Freedman BI
Nephrol Dial Transplant; 2014 Mar; 29(3):587-94. PubMed ID: 24157943
[TBL] [Abstract][Full Text] [Related]
26. HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics.
Atta MG; Estrella MM; Kuperman M; Foy MC; Fine DM; Racusen LC; Lucas GM; Nelson GW; Warner AC; Winkler CA; Kopp JB
Kidney Int; 2012 Aug; 82(3):338-43. PubMed ID: 22495294
[TBL] [Abstract][Full Text] [Related]
27. Joint Associations of Maternal-Fetal APOL1 Genotypes and Maternal Country of Origin With Preeclampsia Risk.
Hong X; Rosenberg AZ; Zhang B; Binns-Roemer E; David V; Lv Y; Hjorten RC; Reidy KJ; Chen TK; Wang G; Ji Y; Simpson CL; Davis RL; Kopp JB; Wang X; Winkler CA
Am J Kidney Dis; 2021 Jun; 77(6):879-888.e1. PubMed ID: 33359152
[TBL] [Abstract][Full Text] [Related]
28. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
Freedman BI; Pastan SO; Israni AK; Schladt D; Julian BA; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Mohan S; Ma L; Langefeld CD; Bowden DW; Hicks PJ; Palmer ND; Palanisamy A; Reeves-Daniel AM; Brown WM; Divers J
Transplantation; 2016 Jan; 100(1):194-202. PubMed ID: 26566060
[TBL] [Abstract][Full Text] [Related]
29. APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline.
Peralta CA; Bibbins-Domingo K; Vittinghoff E; Lin F; Fornage M; Kopp JB; Winkler CA
J Am Soc Nephrol; 2016 Mar; 27(3):887-93. PubMed ID: 26180129
[TBL] [Abstract][Full Text] [Related]
30. APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans.
Kasembeli AN; Duarte R; Ramsay M; Mosiane P; Dickens C; Dix-Peek T; Limou S; Sezgin E; Nelson GW; Fogo AB; Goetsch S; Kopp JB; Winkler CA; Naicker S
J Am Soc Nephrol; 2015 Nov; 26(11):2882-90. PubMed ID: 25788523
[TBL] [Abstract][Full Text] [Related]
31. APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes.
Freedman BI; Langefeld CD; Lu L; Palmer ND; Smith SC; Bagwell BM; Hicks PJ; Xu J; Wagenknecht LE; Raffield LM; Register TC; Carr JJ; Bowden DW; Divers J
Kidney Int; 2015 Jan; 87(1):176-81. PubMed ID: 25054777
[TBL] [Abstract][Full Text] [Related]
32. Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension Trial.
Bodonyi-Kovacs G; Ma JZ; Chang J; Lipkowitz MS; Kopp JB; Winkler CA; Le TH
J Am Soc Nephrol; 2016 Oct; 27(10):3140-3152. PubMed ID: 26940095
[TBL] [Abstract][Full Text] [Related]
33. Population-based risk assessment of APOL1 on renal disease.
Friedman DJ; Kozlitina J; Genovese G; Jog P; Pollak MR
J Am Soc Nephrol; 2011 Nov; 22(11):2098-105. PubMed ID: 21997396
[TBL] [Abstract][Full Text] [Related]
34. APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.
Mukamal KJ; Tremaglio J; Friedman DJ; Ix JH; Kuller LH; Tracy RP; Pollak MR
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):398-403. PubMed ID: 26634651
[TBL] [Abstract][Full Text] [Related]
35. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
Kopp JB; Nelson GW; Sampath K; Johnson RC; Genovese G; An P; Friedman D; Briggs W; Dart R; Korbet S; Mokrzycki MH; Kimmel PL; Limou S; Ahuja TS; Berns JS; Fryc J; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Vlahov D; Pollak M; Winkler CA
J Am Soc Nephrol; 2011 Nov; 22(11):2129-37. PubMed ID: 21997394
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein L1 High-Risk Genotypes and Albuminuria in Sub-Saharan African Populations.
Brandenburg JT; Govender MA; Winkler CA; Boua PR; Agongo G; Fabian J; Ramsay M
Clin J Am Soc Nephrol; 2022 Jun; 17(6):798-808. PubMed ID: 35577564
[TBL] [Abstract][Full Text] [Related]
37. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.
Freedman BI; Langefeld CD; Turner J; Núñez M; High KP; Spainhour M; Hicks PJ; Bowden DW; Reeves-Daniel AM; Murea M; Rocco MV; Divers J
Kidney Int; 2012 Oct; 82(7):805-11. PubMed ID: 22695330
[TBL] [Abstract][Full Text] [Related]
38. JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.
Divers J; Núñez M; High KP; Murea M; Rocco MV; Ma L; Bowden DW; Hicks PJ; Spainhour M; Ornelles DA; Kleiboeker SB; Duncan K; Langefeld CD; Turner J; Freedman BI
Kidney Int; 2013 Dec; 84(6):1207-13. PubMed ID: 23677244
[TBL] [Abstract][Full Text] [Related]
39. Genetic variation in APOL1 associates with younger age at hemodialysis initiation.
Kanji Z; Powe CE; Wenger JB; Huang C; Ankers E; Sullivan DA; Collerone G; Powe NR; Tonelli M; Bhan I; Bernhardy AJ; Dibartolo S; Friedman D; Genovese G; Pollak MR; Thadhani R
J Am Soc Nephrol; 2011 Nov; 22(11):2091-7. PubMed ID: 21997398
[TBL] [Abstract][Full Text] [Related]
40. A tripartite complex of suPAR, APOL1 risk variants and α
Hayek SS; Koh KH; Grams ME; Wei C; Ko YA; Li J; Samelko B; Lee H; Dande RR; Lee HW; Hahm E; Peev V; Tracy M; Tardi NJ; Gupta V; Altintas MM; Garborcauskas G; Stojanovic N; Winkler CA; Lipkowitz MS; Tin A; Inker LA; Levey AS; Zeier M; Freedman BI; Kopp JB; Skorecki K; Coresh J; Quyyumi AA; Sever S; Reiser J
Nat Med; 2017 Aug; 23(8):945-953. PubMed ID: 28650456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
